Full Breakdown
WTA’s Mandatory Gene-Testing Policy Gains Top Player’s Backing
8/5/2026, 5:44:07 PM
Policy Overview and Sabalenka’s Comments
The Women’s Tennis Association (WTA) announced a one-time genetic screening for the SRY gene—normally located on the Y chromosome—to be applied to every player. The policy, aimed at distinguishing biological females from biological males, took effect on July 21. During a press conference at the 2026 National Bank Open in Toronto, world No. 1 Aryna Sabalenka of Belarus said she supports the measure, emphasizing the need to preserve “fairness in our tour.”
Implementation Timeline
- July 21, 2026 – Mandatory SRY-gene testing begins for all WTA players.
- August 2, 2026 – Sabalenka addressed the policy at a scheduled press conference ahead of her Round-of-64 match at the National Bank Open.
- 2028 Los Angeles Olympics – The WTA states the one-off test will be required for athletes who wish to compete in the Olympic Games.
Official Statements & Responses
Sabalenka’s public endorsement aligns with the WTA’s framing of the rule as a fairness safeguard rather than a political statement.
Why It Matters
By linking eligibility to a biological marker, the WTA seeks to address ongoing debates over transgender athletes’ participation in women’s competition. The policy’s extension to the 2028 Olympics could set a precedent for other sports governing bodies, potentially reshaping eligibility standards across international competition.
Verbatim Quotes
- “I think it’s really important to keep the fairness in our tour,” — Aryna Sabalenka, reporter
